Skip to content

NovoCure NVCR Commitments & Contingencies

Commitments & Contingencies at other companies

Hagerty logo
HagertyHGTY
$0
Global Net Lease logo
Global Net LeaseGNL
$0
Piedmont Office Realty Trust logo
Piedmont Office Realty TrustPDM
$0
OGS
ONE GASOGS
$0
Corebridge Financial logo
Corebridge FinancialCRBG
$3.4B+30.8%
National Fuel Gas logo
National Fuel GasNFG
$0

Other financials

Income statement

See full
Revenue$174.1M+12.3%
Gross profit$135.1M+16.0%
Operating income-$67.4M-78.1%
Net income-$71.1M-107%
EPS (diluted)-$0.62-100%

Balance sheet

See full
Cash & equivalents$87.5M-31.2%
Total debt$39.5M-2.1%
Total equity$330.7M-8.6%
Total assets$787.9M-36.9%

Cash flow

See full
Operating cash flow-$13.5M+62.1%
CapEx$5.2M-51.4%
Free cash flow-$18.7M+59.7%

Valuation

See full
Market cap$1.7B-36.7%
Enterprise value$1.66B-36.3%
P/S2.5×-1.8×

Profitability

See full
Gross margin75.2%-2.0pp
Operating margin-27.2%+0.4pp
Net margin-25.7%-0.7pp
FCF margin-7.1%-2.0pp

Returns & leverage

See full
Return on equity-50%+5.4pp
Debt / equity0.1×0.0×
Current ratio2.9×+1.4×

Where this comes from

Reported directly by NovoCure in its filing.

Tagged under the XBRL concept us-gaap:CommitmentsAndContingencies.

The official record: NovoCure’s 10-Q, filed July 25, 2019, on SEC EDGAR. View the filing →